Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues...

• Date :
• 4    
  0

Updates and Controversies in HER2-Positive Breast Cancer

• Date :
• 3    
  0

Lung Cancer Screening With Low-Dose CT: Implementation Amid Changing Public Policy at One Health Care System

• Date :
• 2    
  0

Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information

• Date :
• 2    
  0

Enhancing Care of the Survivor of Gynecologic Cancer: Managing the Menopause and Radiation Toxicity

• Date :
• 1    
  0

Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment

• Date :
• 1    
  0

Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?

• Date :
• 1    
  0

Functional Imaging Using 18-Fluorodeoxyglucose PET in the Management of Primary Mediastinal Large B-Cell Lymphoma: The Contributions of the International Extranodal Lymphoma Study Group

• Date :
• 1    
  0

The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

• Date :
• 1    
  0

The Oncology Care Model: A Critique

• Date :
• 1    
  0

Tailoring Chemotherapy in Early-Stage Breast Cancer: Based on Tumor Biology or Tumor Burden?

• Date :
• 1    
  0

Interrogating the Cancer Genome to Deliver More Precise Cancer Care

• Date :
• 1    
  0

Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications

• Date :
• 1    
  0

Surgical Management and Adjuvant Therapy for High-Risk and Metastatic Melanoma

• Date :
• 1    
  0

Strategies for Sustainable Cancer Care

• Date :
• 1    
  0

Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes

• Date :
• 1    
  0

Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco

• Date :
• 1    
  0

Manipulating the Immune System With Checkpoint Inhibitors for Patients With Metastatic Sarcoma

• Date :
• 1    
  0

Minimal Residual Disease by Next-Generation Sequencing: Pros and Cons

• Date :
• 1    
  0

Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be More

• Date :
• 1    
  0

Neuroblastoma: A Tough Nut to Crack

• Date :
• 1    
  0

Transforming Clinical Trial Eligibility Criteria to Reflect Practical Clinical Application

• Date :
• 1    
  0

Tumor Heterogeneity and Therapeutic Resistance

• Date :
• 1    
  0

Developing High-Quality Cancer Rehabilitation Programs: A Timely Need

• Date :
• 1    
  0

Contemporary Active Surveillance for Prostate Cancer: Do We Need Better Imaging and Molecular Testing?

• Date :
• 1    
  0

Treatment of Lung Cancer in Medically Compromised Patients

• Date :
• 1    
  0

Why the Quality Oncology Practice Initiative Matters: It's Not Just About Cost

• Date :
• 1    
  0

Biomarkers for Immunotherapy: Current Developments and Challenges

• Date :
• 1    
  0

Advances in the Genetics and Therapy of Acute Lymphoblastic Leukemia

• Date :
• 1    
  0

Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome

• Date :
• 1    
  0

Chemoimmunotherapy Versus Targeted Treatment in Chronic Lymphocytic Leukemia: When, How Long, How Much, and in Which Combination?

• Date :
• 1    
  0

Considerations for Implementation of Cancer Molecular Diagnostics Into Clinical Care

• Date :
• 1    
  0

What's New in Head and Neck Cancer: Key Findings in 2015-2016 From ECCO/ESMO, ASTRO, and the Multidisciplinary Head and Neck Cancer Symposium

• Date :
• 0    
  0

Real-World Conundrums and Biases in the Use of White Cell Growth Factors

• Date :
• 0    
  0

Updated Diagnostic Criteria and Staging System for Multiple Myeloma

• Date :
• 0    
  0

Using Technology to Improve Cancer Care: Social Media, Wearables, and Electronic Health Records

• Date :
• 0    
  0

Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies

• Date :
• 0    
  0

Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

• Date :
• 0    
  0

Oncology Advanced Practitioners Bring Advanced Community Oncology Care

• Date :
• 0    
  0

Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer

• Date :
• 0    
  0

Overcoming Therapeutic Resistance by Targeting Cancer Inflammation

• Date :
• 0    
  0

The Role of Nephrectomy for Kidney Cancer in the Era of Targeted and Immune Therapies

• Date :
• 0    
  0

Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer

• Date :
• 0    
  0

Risk-Adapted Treatment of Advanced Hodgkin Lymphoma With PET-CT

• Date :
• 0    
  0

Seeking New Approaches to Patients With Small Cell Lung Cancer

• Date :
• 0    
  0

Treatment of Older Women With Endometrial Cancer: Improving Outcomes With Personalized Care

• Date :
• 0    
  0

Treatment of Muscle-Invasive Bladder Cancer in Older Patients

• Date :
• 0    
  0

Targeted Therapy in Brain Metastases: Ready for Primetime?

• Date :
• 0    
  0

The Advantages and Challenges of Testing Children for Heritable Predisposition to Cancer

• Date :
• 0    
  0

The Cancer Survivorship Journey: Models of Care, Disparities, Barriers, and Future Directions

• Date :
• 0    
  0

The Evolution of Systemic Therapy in Metastatic Renal Cell Carcinoma

• Date :
• 0    
  0

The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics

• Date :
• 0    
  0

Electronic Patient-Reported Outcomes: The Time Is Ripe for Integration Into Patient Care and Clinical Research

• Date :
• 0    
  0

The Past, Present, and Future of Pancreatic Cancer Clinical Trials

• Date :
• 0    
  0

Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine

• Date :
• 0    
  0

The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016

• Date :
• 0    
  0

Compassionate Use: A Modest Proposal

• Date :
• 0    
  0

How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing

• Date :
• 0    
  0

Gastric Adenocarcinoma: An Update on Genomics, Immune System Modulations, and Targeted Therapy

• Date :
• 0    
  0

Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders

• Date :
• 0    
  0

Evolving Recommendations on Prostate Cancer Screening

• Date :
• 0    
  0

Emerging Therapeutic Options for HER2-Positive Breast Cancer

• Date :
• 0    
  0

Emerging Molecular Biomarkers in Advanced Prostate Cancer: Translation to the Clinic

• Date :
• 0    
  0

Discussing the Evidence for Upstream Palliative Care in Improving Outcomes in Advanced Cancer

• Date :
• 0    
  0

Current State of Immune-Based Therapies for Glioblastoma

• Date :
• 0    
  0

Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder

• Date :
• 0    
  0

Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer

• Date :
• 0    
  0

Challenges in Treating Premenopausal Women with Endocrine-Sensitive Breast Cancer

• Date :
• 0    
  0

Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions

• Date :
• 0    
  0

Biosimilars: Here and Now

• Date :
• 0    
  0

Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling

• Date :
• 0    
  0

Basic Overview of Current Immunotherapy Approaches in Cancer

• Date :
• 0    
  0

Approach to Oligometastatic Prostate Cancer

• Date :
• 0    
  0

Addressing Burnout in Oncology: Why Cancer Care Clinicians Are At Risk, What Individuals Can Do, and How Organizations Can Respond

• Date :
• 0    
  0

Access to Cancer Therapeutics in Low- and Middle-Income Countries

• Date :
• 0    
  0

Local Ablative Therapies to Metastatic Soft Tissue Sarcoma

• Date :
• 0    
  0

New Targets and New Agents in High-Risk Multiple Myeloma

• Date :
• 0    
  0

Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune Therapy

• Date :
• 0    
  0

Gynecologic Cancers: Emerging Novel Strategies for Targeting DNA Repair Deficiency

• Date :
• 0    
  0

Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors

• Date :
• 0    
  0

Challenges and Opportunities in Delivering High-Quality Cancer Care: A 2016 Update

• Date :
• 0    
  0

Locoregional Recurrent or Second Primary Head and Neck Cancer: Management Strategies and Challenges

• Date :
• 0    
  0

Localized Pancreatic Cancer: Multidisciplinary Management

• Date :
• 0    
  0

Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit?

• Date :
• 0    
  0

Next-Generation Sequencing Informing Therapeutic Decisions and Personalized Approaches

• Date :
• 0    
  0

Liver Metastases in Colorectal Cancer

• Date :
• 0    
  0

Less Is More: The Evolving Surgical Approach to Breast Cancer

• Date :
• 0    
  0

Issues on the Use of White Blood Cell Growth Factors in Oncology Practice

• Date :
• 0    
  0

Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes

• Date :
• 0    
  0

Individualizing Care for Patients With Myeloproliferative Neoplasms: Integrating Genetics, Evolving Therapies, and Patient-Specific Disease Burden

• Date :
• 0    
  0

Improving Response to Hormone Therapy in Breast Cancer: New Targets, New Therapeutic Options

• Date :
• 0    
  0

Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies

• Date :
• 0    
  0

Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away

• Date :
• 0    
  0

Congrès ESMO 2026

• Date :
• 801    
  0

Congrès ESMO d'Immuno-Oncologie 2025

• Date :
• 1316    
  0

SABCS 2025 Symposium

• Date :
• 7714    
  0

Congrès ESMO Asie 2025

• Date :
• 951    
  0

17ᵉ Congrès Européen Multidisciplinaire sur le Cancer Urologique - EMUC25

• Date :
• 1417    
  0